Pharmaceutical compositions comprising fatty acids
AssigneeAmarin Pharmaceuticals Ireland Limited
InventorsIan Osterloh, Pierre Wicker, Rene Braeckman, Paresh Soni, Mehar Manku
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to, inter alia, methods of treating mixed dyslipidemia with ethyl eicosapentaenoate.
Claims24
A pharmaceutical composition comprising eicosapentaenoic acid (EPA) or a derivative of EPA, docosahexaenoic acid (DHA) or a derivative of DHA, and at least one surfactant.
A pharmaceutical composition comprising a mixture of ethyl-EPA and ethyl-DHA in a ratio of about 2:1 to about 3.5:1, Polysorbate 80 in an amount from about 0.25% to about 15% by weight of the pharmaceutical composition and polyoxypropylene block copolymer in an amount from about 0.25% to about 15% by weight of the pharmaceutical composition.
Dependencies are inferred from the claim text.